500 Fifth Avenue, 47th Floor,
New York, New York 10110
Graycliff Partners is a private equity firm focused on private equity and mezzanine investments in middle-market companies throughout the US and Latin America. The Firm's mezzanine practice does not have any sector preferences and looks to invest $5 to $25 million in profitable companies with at least $10 million in revenue. Funds are used to support buyouts, growth needs, divestitures, or consolidations. Graycliff's private equity group looks to acquire middle-market companies in the manufacturing, service, and distribution companies. The Firm looks for opportunities valued from $20 to $75 million. Graycliff Partners was originally established in 1991 and is based in New York City.
Join Mergr to view the latest updates and news from New York-based Graycliff Partners.
In the last 3 years, Graycliff Partners has acquired 4 companies. It has also invested in 4 others.
Graycliff Partners’ most common sectors for investment are manufacturing (14%) and distribution (10%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (47%) and growth capital (19%). In total, Graycliff Partners has invested in 14 US states and 7 different countries. Its largest (disclosed) acquisition occurred in 2008 when it acquired Aptalis Pharma for $1.3B.
In the last 3 years, Graycliff Partners has exited 7 companies. The Firm’s most common exit type is trade sale (59%). Graycliff Partners’ largest (disclosed) exit occurred in 2014 when it sold Aptalis Pharma for $2.9B.
Join Mergr to view Graycliff Partners’ full profile and discover more large private equity firms just like it.
No obligation. Cancel anytime.